Topic Editors

Department of Heart Failure and Transplantology, National Institute of Cardiology, Alpejska 42, 04-628 Warszawa, Poland
Dr. Anna Konopka
Department of Intensive Cardiac Therapy, National Institute of Cardiology, Alpejska 42, 04-628 Warszawa, Poland

Biomarkers in Cardiovascular Disease—Chances and Risks

Abstract submission deadline
closed (1 March 2023)
Manuscript submission deadline
closed (31 July 2023)
Viewed by
78137

Topic Information

Dear Colleagues,

I cordially invite you to submit your valuable work covering a very interesting topic: “Biomarkers in Cardiovascular Disease—Chances and Risks”, a rapidly evolving field in recent years.

A proper diagnosis of many cardiac diseases such as myocardial infarction, heart failure, and inborn defects of metabolism relies on the adequate use of biomarkers. In some situations, the information received can be decisive for treatment. In others, together with the results of other investigations, the use of biomarkers can accelerate proper diagnosis and treatment.

There is a growing role of multiple biomarkers in the risk models for prognosis in cardiovascular diseases—their use in prognostic models or in the validation of biomarker-based models are welcome as part of this topic.

Another fascinating and rapidly growing field is the use of Artificial Intelligence prognostic.

Despite the long history of biomarkers in cardiovascular medicine, there are still many unsolved questions about the reproducibility, measurement accuracy, influence of external factors, and the true sensitivity, specificity, and biological significance of those tests—herein, I see a clear limitation to and risk of wide biomarker use.

Every biomarker should be extensively tested before its clinical acceptance and wider use in clinical settings—I hope that your work will contribute enormously to the quest for the ideal biomarker in cardiovascular diseases.

I look forward to see your scientific contribution to this fascinating field.

Prof. Dr. Tomasz Zieliński
Dr. Anna Konopka
Topic Editors

Keywords

  • biomarkers
  • cardiovascular disease
  • diagnosis
  • prognosis
  • risk models

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cardiogenetics
cardiogenetics
0.5 - 2011 43.2 Days CHF 1400
Hearts
hearts
- - 2020 18.5 Days CHF 1000
Journal of Cardiovascular Development and Disease
jcdd
2.4 2.6 2014 22.9 Days CHF 2700
Journal of Clinical Medicine
jcm
3.0 5.7 2012 17.3 Days CHF 2600
Medicina
medicina
2.4 3.3 1920 17.8 Days CHF 2200

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (38 papers)

Back to TopTop